Cite
HARVARD Citation
Kay, J. et al. (n.d.). AB0420 Secondary Efficacy Outcomes from a Phase 3 Study Support Clinical Equivalence Between BOW015 and Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses. Annals of the rheumatic diseases. p. 1034. [Online].